Use of amfonelic acod to discriminate between classical and atypical neuroleptics and neurotensin: an in vivo voltammetric study (Q48767158)

15 February 2018

reason for preferred rank

title

Use of amfonelic acod to discriminate between classical and atypical neuroleptics and neurotensin: an in vivo voltammetric study (English)

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

26 October 2022

Use of amfonelic acid to discriminate between classical and atypical neuroleptics and neurotensin: an in vivo voltammetric study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1677303

26 October 2022

author name string

R. Rivest

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1677303

26 October 2022

F. B. Jolicoeur

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1677303

26 October 2022

C. A. Marsden

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1677303

26 October 2022

language of work or name

English

0 references

publication date

1 March 1991

1 reference

15 February 2018

22 March 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1677303

full work available at URL

26 October 2022

https://api.elsevier.com/content/article/PII:0006899391908883?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

https://api.elsevier.com/content/article/PII:0006899391908883?httpAccept=text/plain

26 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

26 October 2022

1 reference

15 February 2018

volume

544

1 reference

15 February 2018

issue

1

1 reference

15 February 2018

page(s)

86-93

1 reference

15 February 2018

Pharmacologic properties and mechanism of action of amfonelic acid

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Neurotensin in vitro markedly reduces the affinity in subcortical limbic 3H-N-propylnorapomorphine binding sites.

26 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Biochemical differentiation of amphetamine vs methylphenidate and nomifensine in rats

26 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

26 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.

26 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems

26 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Biochemical and behavioural properties of clozapine

26 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Differential pulse voltammetry: simultaneous in vivo measurement of ascorbic acid, catechols and 5-hydroxyindoles in the rat striatum.

26 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

26 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

The nucleus accumbens–possible site of antipsychotic action of neuroleptic drugs?

26 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Antagonism of the apomorphine-induced yawning by “atypical” neuroleptics

26 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Neurotensin blocks certain amphetamine-induced behaviours

26 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Interactions of neurotensin with dopamine-containing neurons in the central nervous system

26 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Direct in vivo monitoring of dopamine released from two striatal compartments in the rat.

26 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics

26 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Neurotensin concentrations in rat striatum and nucleus accumbens: Further studies of their regulation.

26 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Flumezapine and zotepine: 5-hydroxytryptamine antagonism not involved in the lack of synergism of these antipsychotic drugs with amfonelic acid in rats.

26 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Tardive dyskinesia during and following treatment with haloperidol, haloperidol + biperiden, thioridazine, and clozapine

26 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons

26 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen

26 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis

26 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Neurotensin affects hyperactivity but not stereotypy induced by pre and post synaptic dopaminergic stimulation

26 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

The effects of neurotensin and [D-Tyr11]-NT on the hyperactivity induced by intra-accumbens administration of a potent dopamine receptor agonist

26 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

The effects of amfonelic acid and some other central stimulants on mouse striatal tyramine, dopamine and homovanillic acid

26 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Neurotensin microinjection into the nucleus accumbens antagonizes dopamine-induced increase in locomotion and rearing.

26 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Neurotensin modulates dopamine neurotransmission at several levels along brain dopaminergic pathways

26 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Acute thioridazine stimulates mesolimbic but not nigrostriatal dopamine release: demonstration by in vivo electrochemistry

26 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Classification of neuroleptic drugs according to their ability to inhibit apomorphine-induced locomotion and gnawing: Evidence for two different mechanisms of action

26 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Acute administration of clozapine, thioridazine and metoclopramide increases extracellular DOPAC and decreases extracellular 5-HIAA, measured in the nucleus accumbens and striatum of the rat using in vivo voltammetry

26 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

In vivo voltammetry--present electrodes and methods

26 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Comparative effects of classical and atypical antipsychotic drugs in combination with a non-amphetamine stimulant on rat brain dopamine metabolism

26 October 2022

40

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Anti-muscarinic properties of neuroleptics and drug-induced Parkinsonism

26 October 2022

42

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Effects of amphetamine and amfonelic acid on the disposition of striatal newly synthesized dopamine

26 October 2022

43

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Modulation of dopamine D1 receptor binding by neurotensin in the rat striatum.

26 October 2022

44

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

The interaction of neurotensin with dopaminergic pathways in the central nervous system: basic neurobiology and implications for the pathogenesis and treatment of schizophrenia.

26 October 2022

47

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Differences in dopamine release and metabolism in rat striatal subregions following acute clozapine using in vivo microdialysis.

26 October 2022

48

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Pharmacological characteristics of dopamine receptors involved in the dual effect of dopamine agonists on yawning behaviour in rats.

26 October 2022

50

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Interactions between neurotensin and dopamine in the brain: An overview

26 October 2022

51

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Autoradiographic evidence for the localization of high affinity neurotensin binding sites on dopaminergic nerve terminals in the nigrostriatal and mesolimbic pathways in rat brain

26 October 2022

52

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Antipsychotic drug doses and neuroleptic/dopamine receptors

26 October 2022

53

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Electrophysiological effects of neurotensin on dopaminergic neurones of the ventral tegmental area of the rat in vitro

26 October 2022

54

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Changes in monoamine metabolites measured by simultaneous in vivo differential pulse voltammetry and intracerebral dialysis.

26 October 2022

55

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Actions of amfonelic acid and other non-amphetamine stimulants on the dopamine neuron

26 October 2022

56

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Actions of dopamine antagonists on stimulated striatal and limbic dopamine release: an in vivo voltammetric study

26 October 2022

57

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Atypical antipsychotic drugs block selective components of amphetamine-induced stereotypy

26 October 2022

58

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

On the relevance of preferential increases of mesolimbic versus striatal dopamine turnover for the prediction of antipsychotic activity of psychotropic drugs

26 October 2022

59

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Discrimination of neuroleptics by means of their interaction with amfonelic acid: an attempt to characterize the test

26 October 2022

60

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Dopamine re-uptake inhibitors show inconsistent effects on the in vivo release of dopamine as measured by intracerebral dialysis in the rat

26 October 2022

61

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons

26 October 2022

62

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Neurotensin receptor localization by light microscopic autoradiography in rat brain

26 October 2022

64

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis

26 October 2022

65

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90888-3

26 October 2022

Identifiers

1 reference

15 February 2018

1 reference

15 February 2018